# Question 22

**Type:** Survival Analysis

**Question:** Do patients with PIK3CA mutations have different overall survival outcomes compared to PIK3CA wild-type patients in breast cancer from the MSK-CHORD Study?

**Answer:**

**URL**: https://www.cbioportal.org/results/comparison/survival?Action=Submit&RPPA_SCORE_THRESHOLD=2.0&Z_SCORE_THRESHOLD=2.0&cancer_study_list=brca_mskchord_2024&case_set_id=brca_mskchord_2024_sequenced&clinicallist=NUM_SAMPLES_PER_PATIENT%2CPROFILED_IN_brca_mskchord_2024_mutations&data_priority=0&gene_list=PIK3CA&geneset_list=%20&genetic_profile_ids_PROFILE_COPY_NUMBER_ALTERATION=brca_mskchord_2024_cna&genetic_profile_ids_PROFILE_MUTATION_EXTENDED=brca_mskchord_2024_mutations&profileFilter=mutations&tab_index=tab_visualize

I've routed you to the **Comparison/Survival** page in cBioPortal for the MSK-CHORD breast cancer study, with patients grouped by PIK3CA mutation status.

On this page, you'll find:
- **Kaplan-Meier survival curves** comparing overall survival between PIK3CA-mutant and PIK3CA wild-type patients
- **Statistical analysis** including log-rank test p-values and hazard ratios
- **Patient counts** in each group
- Options to adjust survival analysis parameters and explore other clinical endpoints if available

You can analyze the survival data directly to answer your question about whether PIK3CA mutations are associated with different overall survival outcomes in this cohort.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 8.973616480012424
- **agent_type**: cbio-nav-null

### Usage
- **input_tokens**: 562
- **output_tokens**: 381
- **total_tokens**: 943
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:36:20*